Open
Notice of Early Expiration of PAR-25-099, "Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)"
National Institutes of Health (NIH)
About this opportunity
National Institute of Allergy and Infectious Diseases (NIAID) The purpose of this Notice is to inform the extramural community that PAR-25-099, “Planning for Product Development Strategy (R34 Clinical Trial Not Allowed),” will be expired effective immediately. No further applications will be accepted for this notice of funding opportunity (NOFO). National Institute of Allergy and Infectious Diseases (NIAID)[email protected]
Finding similar opportunities...